BPI-317753
N/A
Report date: 2025/05/09 15:53:44
NME
Base Information
Drug NameBPI-317753
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesBetta Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBetta Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A